×

What are you searching for?

☰ Menu

News

4 Min read

KNOW MORE ABOUT “LIFE-SAVER” FAVIPIRAVIR LAUNCHED BY GLENMARK TO TREAT MILD COVID-19 CASES

Published On 21 Jun 2020 09:16 AM

SHARE THIS ARTICLE

 13512

 1626

Highlights:

Favipiravir the new antiviral drug is being manufactured by Indian pharma firm Glenmark.
Favipiravir is effective in mild to moderate cases.
The drug Favipiravir will be beneficial for people having conditions heart disease and diabetes having mild or moderate symptoms

....

Click here to read more

Tags : Favipiravir, Glenmark, COVID-19,

SHARE THIS ARTICLE

Leave a comment Cancel Reply

comments (0)

Recent Posts

According to the White House, Biden was not exposed to the question regarding Israel's decision to postpone its ground invasion of Gaza.

Asia's leading graphite producer, China, will restrict exports of a crucial battery material.

Japan requests Google to reverse the names of contested islets in the East China Sea.

Israel Rectifies Greta Thunberg's Post Regarding Gaza By Stating, "Hamas Doesn't..."

"A great deal of suffering": Jews in Europe anticipate an increase in antisemitism in the wake of the Hamas attack.

Airport and Versailles evacuations are prompted by French arrests following bomb concerns.

A man who is charged with bringing firearms onto the grounds of the Wisconsin State Capitol has pleaded not guilty to the misdemeanor charge.

Jeju Shinhwa World provides customized staycations for all visitors.

The GSDF Osprey makes its maiden voyage to Okinawa.

Conflict between Israel and Hamas: India demands strict compliance with international humanitarian law

Relations between Israel and its Arab neighbors in the Middle East

Eight airports in France have received security notifications.

A prospective Biden visit to Israel is fraught with political and security obstacles.

Physicians vow to oppose the government's plan to increase medical school quotas.

The economy minister of Japan pays a visit to Yasukuni Shrine prior to the autumn festival.